Icelandic version
Book appointment

Our tests

The LumiraDx platform was chosen first and foremost for its precision, which is among the best in its class. It’s fast processing time and reliable results help us deliver on our goal of providing great service and fast results to you the customer.

In clinical studies, the LumiraDx SARS-CoV-2 antigen test demonstrated 97.6% positive agreement versus RT-PCR in patients tested within 12 days of the onset of symptoms, to enable the physician to verify infection quickly, begin proper treatment and to initiate isolation precautions helping prevent further spread of infection.

100% positive agreement was achieved with samples with cycle threshold values (ct) < 33
(Roche Cobas 6800 SARS-CoV-2 reference method)